staurosporine aglycone has been researched along with Neoplasms in 3 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mahindroo, N | 1 |
Punchihewa, C | 1 |
Fujii, N | 1 |
Naik, R | 1 |
Ban, HS | 1 |
Jang, K | 1 |
Kim, I | 1 |
Xu, X | 1 |
Harmalkar, D | 1 |
Shin, SA | 1 |
Kim, M | 1 |
Kim, BK | 1 |
Park, J | 1 |
Ku, B | 1 |
Oh, S | 1 |
Won, M | 1 |
Lee, K | 1 |
Peruzzi, B | 1 |
Bottaro, DP | 1 |
2 reviews available for staurosporine aglycone and Neoplasms
Article | Year |
---|---|
Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
Topics: Antineoplastic Agents; Drug Discovery; Hedgehog Proteins; Humans; Neoplasms; Signal Transduction; Tr | 2009 |
Targeting the c-Met signaling pathway in cancer.
Topics: Antineoplastic Agents; Carbazoles; Enzyme Inhibitors; Humans; Indole Alkaloids; Neoplasms; Proto-Onc | 2006 |
1 other study available for staurosporine aglycone and Neoplasms
Article | Year |
---|---|
Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism.
Topics: Anilides; Animals; Cell Line, Tumor; Enzyme Inhibitors; Humans; Isoenzymes; Malate Dehydrogenase; me | 2017 |